Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Lennart Essmann, Yannick Wirz, Claudia Gregoriano & Philipp Schuetz. (2023) One biomarker does not fit all: tailoring anti-infective therapy through utilization of procalcitonin and other specific biomarkers. Expert Review of Molecular Diagnostics 23:9, pages 739-752.
Read now
Read now
Selina Wolfisberg, Claudia Gregoriano & Philipp Schuetz. (2022) Procalcitonin for individualizing antibiotic treatment: an update with a focus on COVID-19. Critical Reviews in Clinical Laboratory Sciences 59:1, pages 54-65.
Read now
Read now
Ellen Haag, Alexandra Molitor, Claudia Gregoriano, Beat Müller & Philipp Schuetz. (2020) The value of biomarker-guided antibiotic therapy. Expert Review of Molecular Diagnostics 20:8, pages 829-840.
Read now
Read now
Justin J. Choi & Matthew W. McCarthy. (2018) Novel applications for serum procalcitonin testing in clinical practice. Expert Review of Molecular Diagnostics 18:1, pages 27-34.
Read now
Read now
Articles from other publishers (48)
Allison B Chambliss, Khushbu Patel, Jessica M Colón-Franco, Joshua Hayden, Sophie E Katz, Emi Minejima & Alison Woodworth. (2023) AACC Guidance Document on the Clinical Use of Procalcitonin. The Journal of Applied Laboratory Medicine 8:3, pages 598-634.
Crossref
Crossref
Philipp Schuetz. (2023) How to best use procalcitonin to diagnose infections and manage antibiotic treatment. Clinical Chemistry and Laboratory Medicine (CCLM) 61:5, pages 822-828.
Crossref
Crossref
Marissa Z. Powell, Kristin C. Mara, Radhika Bansal, Matthew A. Hathcock, Arushi Khurana, N. Nora Bennani, Yucai Wang, Jonas Paludo, Jose Villasboas Bisneto, Stephen M. Ansell, Patrick B. Johnston, Yi Lin & Jason N. Barreto. (2023) Procalcitonin as a biomarker for predicting bacterial infection in chimeric antigen receptor T‐cell therapy recipients. Cancer Medicine 12:8, pages 9228-9235.
Crossref
Crossref
Marco Falcone, Michael Bauer, Ricard Ferrer, Gaëtan Gavazzi, Juan Gonzalez del Castillo, Alberto Pilotto & Philipp Schuetz. (2023) Biomarkers for risk stratification and antibiotic stewardship in elderly patients. Aging Clinical and Experimental Research 35:5, pages 925-935.
Crossref
Crossref
Abderrahim Oussalah, Jonas Callet, Anne-Elisabeth Manteaux, Nathalie Thilly, Nicolas Jay, Jean-Louis Guéant & Alain Lozniewski. (2023) Usefulness of procalcitonin at admission as a risk-stratifying biomarker for 50-day in-hospital mortality among patients with community-acquired bloodstream infection: an observational cohort study. Biomarker Research 11:1.
Crossref
Crossref
Juying Jiao, Jianjun Liu, Qi Li, Guixin Zhang, Chen Pan, Fei Luo, Qingkai Zhang, Bing Qi, Liang Zhao, Peiyuan Yin & Dong Shang. (2022) Gut Microbiota-Derived Diaminopimelic Acid Promotes the NOD1/RIP2 Signaling Pathway and Plays a Key Role in the Progression of Severe Acute Pancreatitis. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Burçin Erdem Kinas, Arzu Etem Akagac, Aybala Erek Toprak, Sule Batcık & Ahmet Rıza Uras. (2022) Comparison of enzyme-linked fluorescent assay and electrochemiluminescence immune assay in procalcitonin measurement. Turkish Journal of Biochemistry 47:1, pages 19-22.
Crossref
Crossref
Aparajita Sen, Arti Nigam & Meenakshi Vachher. (2022) Role of Polypeptide Inflammatory Biomarkers in the Diagnosis and Monitoring of COVID-19. International Journal of Peptide Research and Therapeutics 28:2.
Crossref
Crossref
Gan Luo, Jue Zhang, Yaqi Sun, Ya Wang, Hanbin Wang, Baoli Cheng, Qiang Shu & Xiangming Fang. (2021) Nanoplatforms for Sepsis Management: Rapid Detection/Warning, Pathogen Elimination and Restoring Immune Homeostasis. Nano-Micro Letters 13:1.
Crossref
Crossref
Huu-Hien Huynh, Amandine Bœuf, Jens Pfannkuche, Philipp Schuetz, Marc Thelen, Gunnar Nordin, Eline van der Hagen, Patricia Kaiser, Dagmar Kesseler, Tony Badrick, Bernard Poggi, Ulla Tiikkainen, Gareth J Davies, Anja Kessler, Mario Plebani, Joëlle Vinh & Vincent Delatour. (2021) Harmonization status of procalcitonin measurements: what do comparison studies and EQA schemes tell us?. Clinical Chemistry and Laboratory Medicine (CCLM) 59:10, pages 1610-1622.
Crossref
Crossref
Eva Heilmann, Claudia Gregoriano, Djillali Annane, Konrad Reinhart, Lila Bouadma, Michel Wolff, Jean Chastre, Charles-Edouard Luyt, Florence Tubach, Angela R Branche, Matthias Briel, Mirjam Christ-Crain, Tobias Welte, Caspar Corti, Evelien de Jong, Maarten Nijsten, Dylan W de Lange, Jos A H van Oers, Albertus Beishuizen, Armand R J Girbes, Rodrigo O Deliberato, Stefan Schroeder, Kristina B Kristoffersen, Nathalie Layios, Pierre Damas, Stella S S Lima, Vandack Nobre, Long Wei, Carolina F Oliveira, Yahya Shehabi, Daiana Stolz, Michael Tamm, Alessia Verduri, Jin-Xiang Wang, Sabine Drevet, Gaetan Gavazzi, Beat Mueller & Philipp Schuetz. (2021) Duration of antibiotic treatment using procalcitonin-guided treatment algorithms in older patients: a patient-level meta-analysis from randomized controlled trials. Age and Ageing 50:5, pages 1546-1556.
Crossref
Crossref
William Good, Gene Jeon, Irene Zeng, Louanne Storey, Helen Qiao, Stuart Jones, Sarah Mooney, Lata Jayaram, David Holland & Conroy Wong. (2021) Sputum procalcitonin – a potential biomarker in stable bronchiectasis. ERJ Open Research, pages 00285-2021.
Crossref
Crossref
Maria Calderon, Ang Li, Juan Carlos Bazo-Alvarez, Jonathan Dennis, Kenneth F Baker, Ina Schim van der Loeff, Aidan T Hanrath, Richard Capstick, Brendan A I Payne, Daniel Weiand, Ewan Hunter & Ulrich Schwab. (2021) Evaluation of procalcitonin-guided antimicrobial stewardship in patients admitted to hospital with COVID-19 pneumonia. JAC-Antimicrobial Resistance 3:3.
Crossref
Crossref
Hae Weon Cho, Sun Hee Kim, Yonggeun Cho, Seok Hoon Jeong & Sang-Guk Lee. (2021) Concordance of Three Automated Procalcitonin Immunoassays at Medical Decision Points. Annals of Laboratory Medicine 41:4, pages 419-423.
Crossref
Crossref
Minjing Liao, Jiao Zheng, Ye Xu, Yilan Qiu, Chuan Xia, Zhihong Zhong, Lihui Liu, Hongrong Liu, Rushi Liu & Songyue Liang. (2021) Development of magnetic particle-based chemiluminescence immunoassay for measurement of human procalcitonin in serum. Journal of Immunological Methods 488, pages 112913.
Crossref
Crossref
Kseniya V. Serebrennikova, Jeanne V. Samsonova & Alexander P. Osipov. 2021. Macro, Micro, and Nano-Biosensors. Macro, Micro, and Nano-Biosensors
161
175
.
Yachana Kataria & Daniel Remick. 2021. Sepsis. Sepsis
177
189
.
Yordan Kalchev, Tsetsa Petkova, Ralitsa Raycheva, Bothwell Kabayira, Tanya Deneva & Marianna Murdjeva. (2020) Serum Procalcitonin Levels in Patients with Acute Central Nervous System Infections. Open Access Macedonian Journal of Medical Sciences 8:B, pages 1251-1255.
Crossref
Crossref
S. Perez-San Martin, B. Suberviola, M. T. Garcia-Unzueta, B. A. Lavin, S. Campos & M. Santibañez. (2020) Prognostic value of plasma pentraxin 3 levels in patients with septic shock admitted to intensive care. PLOS ONE 15:12, pages e0243849.
Crossref
Crossref
Paul E. Marik & Elise Stephenson. (2020) The ability of Procalcitonin, lactate, white blood cell count and neutrophil-lymphocyte count ratio to predict blood stream infection. Analysis of a large database. Journal of Critical Care 60, pages 135-139.
Crossref
Crossref
Chien-Chang Lee, Andrea Lay Hoon Kwa, Anucha Apisarnthanarak, Jia-Yih Feng, Eric Howard Gluck, Akihiro Ito, Anis Karuniawati, Petrick Periyasamy, Busadee Pratumvinit, Jeetendra Sharma, Rontgene Solante, Subramanian Swaminathan, Niraj Tyagi, Dien Minh Vu, Kapil Zirpe & Philipp Schuetz. (2020) Procalcitonin (PCT)-guided antibiotic stewardship in Asia-Pacific countries: adaptation based on an expert consensus meeting. Clinical Chemistry and Laboratory Medicine (CCLM) 58:12, pages 1983-1991.
Crossref
Crossref
Gang Wang, Yong Wan, Guanfeng Lin, Zhixiong Li, Zhining Dong & Tiancai Liu. (2020) Development of a novel chemiluminescence immunoassay for the detection of procalcitonin. Journal of Immunological Methods 484-485, pages 112829.
Crossref
Crossref
İsmail DEMİR & İsmail YILMAZ. (2020) The Effect of Polypharmacy on Procalcitonin Levels in The Intensive Care Admission of Geriatric Patients with SepsisYoğun Bakıma Kabul Edilen Sepsisli Geriatrik Hastalarda Polifarmasinin Prokalsitonin Değerlerine Olan Etkisi. Konuralp Tıp Dergisi 12:2, pages 216-222.
Crossref
Crossref
Cristian T. Tonial, Caroline A. D. Costa, Gabriela R. H. Andrades, Francielly Crestani, Paulo R. Einloft, Francisco Bruno, Ana P. Miranda, Humberto H. Fiori & Pedro Celiny R. Garcia. (2020) Prediction of Poor Outcomes for Septic Children According to Ferritin Levels in a Middle-Income Setting*. Pediatric Critical Care Medicine 21:5, pages e259-e266.
Crossref
Crossref
Juncheng Shi, Qiankun Shi, Shoutao Yuan & Wenhao Zhang. (2020) Relationships between serum procalcitonin level, severity and different stresses of non-septic critically ill patients. Revista Romana de Medicina de Laborator 28:1, pages 49-56.
Crossref
Crossref
Anne Marie Dupuy, Anne Sophie Bargnoux, Aneta Andreeva, Charlie Zins, Nils Kuster, Stéphanie Badiou & Jean Paul Cristol. (2020) Analytical performances of a novel point-of-care procalcitonin assay. Practical Laboratory Medicine 18, pages e00145.
Crossref
Crossref
Chien-Chang Lee, Julia Chia-Yu Chang, Xiao-Wei Mao, Wan-Ting Hsu, Shey-Ying Chen, Yee-Chun Chen & Chorng-Kuang How. (2020) Combining Procalcitonin and Rapid Multiplex Respiratory Virus Testing for Antibiotic Stewardship in Older Adult Patients With Severe Acute Respiratory Infection. Journal of the American Medical Directors Association 21:1, pages 62-67.
Crossref
Crossref
Giuseppe Lippi, Gian Luca Salvagno, Matteo Gelati, Mairi Pucci, Claudia Lo Cascio, Davide Demonte, Diego Faggian & Mario Plebani. (2019) Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays. Clinical Chemistry and Laboratory Medicine (CCLM) 58:1, pages 77-84.
Crossref
Crossref
Paul E. Marik. (2019) Procalcitonin is an essential biomarker for hydrocortisone, ascorbic acid, and thiamine (HAT) therapy in patients with sepsis. Critical Care 23:1.
Crossref
Crossref
O. Neeser, A. Branche, B. Mueller & P. Schuetz. (2019) How to: implement procalcitonin testing in my practice. Clinical Microbiology and Infection 25:10, pages 1226-1230.
Crossref
Crossref
Allison B. Chambliss, Joshua Hayden & Jennifer M. Colby. (2019) Evaluation of procalcitonin immunoassay concordance near clinical decision points. Clinical Chemistry and Laboratory Medicine (CCLM) 57:9, pages 1414-1421.
Crossref
Crossref
Abass Eidizadeh, Abdul R. Asif, Nicolas von Ahsen, Lutz Binder & Moritz Schnelle. (2019) Differences in procalcitonin measurements between three BRAHMS-partnered immunoassays (Liaison, Elecsys and Architect). Clinical Chemistry and Laboratory Medicine (CCLM) 57:9, pages e207-e210.
Crossref
Crossref
Nathalie Wojtalewicz, Ingo Schellenberg & Klaus-Peter Hunfeld. (2019) Evaluation of INSTAND e.V.’s external quality assessment for C-reactive protein and procalcitonin. PLOS ONE 14:8, pages e0221426.
Crossref
Crossref
Carly J. PaoliMark A. ReynoldsCourtney ColesMatthew GitlinElliott Crouser. (2019) Predicted Economic Benefits of a Novel Biomarker for Earlier Sepsis Identification and Treatment: A Counterfactual Analysis. Critical Care Explorations 1:8, pages e0029.
Crossref
Crossref
Sebastian Noe, Silke Heldwein & Friedrich W. Tiller. (2019) Entzündungszeichen richtig interpretieren. CME 16:7-8, pages 49-57.
Crossref
Crossref
Valentinas Gruzdys, Kenneth Cahoon, Lauren Pearson & Christopher M Lehman. (2019) Method Verification Shows a Negative Bias between 2 Procalcitonin Methods at Medical Decision Concentrations. The Journal of Applied Laboratory Medicine 4:1, pages 69-77.
Crossref
Crossref
Angela Branche, Olivia Neeser, Beat Mueller & Philipp Schuetz. (2019) Procalcitonin to guide antibiotic decision making. Current Opinion in Infectious Diseases 32:2, pages 130-135.
Crossref
Crossref
Philippe Eggimann, Yok-Ai Que & Fabien Rebeaud. (2019) Measurement of pancreatic stone protein in the identification and management of sepsis. Biomarkers in Medicine 13:2, pages 135-145.
Crossref
Crossref
Rita Murri, Eleonora Taddei, Roberto Cauda & Massimo Fantoni. (2019) Use of procalcitonin as a tool for antibiotic stewardship. Future Microbiology 14:2, pages 77-79.
Crossref
Crossref
Dan Wang, Brittany Caddell, Frederick S Nolte & Nikolina Babic. (2019) Comparison of the Abbott Architect BRAHMS and the Biomérieux Vidas BRAHMS Procalcitonin Assays. The Journal of Applied Laboratory Medicine 3:4, pages 580-586.
Crossref
Crossref
Luís Cabral, Vera Afreixo, Rita Meireles, Miguel Vaz, João-Gonçalo Frade, Catarina Chaves, Marisa Caetano, Luís Almeida & José-Artur Paiva. (2019) Evaluation of Procalcitonin Accuracy for the Distinction Between Gram-Negative and Gram-Positive Bacterial Sepsis in Burn Patients. Journal of Burn Care & Research 40:1, pages 112-119.
Crossref
Crossref
E. Estenssoro. (2018) Another piece to add to the puzzle of procalcitonin in renal dysfunction. Medicina Intensiva (English Edition) 42:7, pages 397-398.
Crossref
Crossref
E. Estenssoro. (2018) Another piece to add to the puzzle of procalcitonin in renal dysfunction. Medicina Intensiva 42:7, pages 397-398.
Crossref
Crossref
Weronika Kolasińska & Agnieszka Jankowska-Kulawy. (2018) Procalcitonin as a diagnostic marker of infections and inflammation. Diagnostyka Laboratoryjna 54:3, pages 179-184.
Crossref
Crossref
Roberta Troia, Massimo Giunti, Stefano Calipa & Robert Goggs. (2018) Cell-Free DNA, High-Mobility Group Box-1, and Procalcitonin Concentrations in Dogs With Gastric Dilatation–Volvulus Syndrome. Frontiers in Veterinary Science 5.
Crossref
Crossref
Yannick Wirz, Angela Branche, Michel Wolff, Tobias Welte, Vandack Nobre, Konrad Reinhart, Ann R. Falsey, Pierre Damas, Albertus Beishuizen, Rodrigo O. Deliberato, Yahya Shehabi, Jens-Ulrik S. Jensen, Beat Mueller & Philipp Schuetz. (2017) Management of Respiratory Infections with Use of Procalcitonin: Moving toward More Personalized Antibiotic Treatment Decisions. ACS Infectious Diseases 3:12, pages 875-879.
Crossref
Crossref
Ferruccio Ceriotti, Irene Marino, Andrea Motta & Anna Carobene. (2017) Analytical evaluation of the performances of Diazyme and BRAHMS procalcitonin applied to Roche Cobas in comparison with BRAHMS PCT-sensitive Kryptor. Clinical Chemistry and Laboratory Medicine (CCLM) 56:1, pages 162-169.
Crossref
Crossref
Viviana Carcamo Yañez, Jens Göpfert, Markus Otto, Hayrettin Tumani, Andreas Peter & Thomas Joos. (2017) Development and Validation of an Ultrasensitive Procalcitonin Sandwich Immunoassay. High-Throughput 6:4, pages 18.
Crossref
Crossref